Coherus BioSciences Inc (NASDAQ:CHRS)

14.13
Delayed Data
As of Mar 25
 -0.19 / -1.33%
Today’s Change
8.32
Today|||52-Week Range
20.66
+56.13%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Coherus BioSciences Inc have a median target of 25.00, with a high estimate of 35.00 and a low estimate of 22.00. The median estimate represents a +76.93% increase from the last price of 14.13.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Coherus BioSciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.03
Sales
$0.00
Reporting Date
May 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 103.26%
 
 
 
 
 
 
Growthannually 30.95%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.